Clinical trial
An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis
NCT00463151 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- August 31, 2008
- Enrollment
- 124 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.